✦ LIBER ✦

2124 POSTER Triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer (MBC): latest results of an international phase II trial

✍ Scribed by A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; O. Perrot; G. Villanova; N. Tubiana-Mathieu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

All-oral combination of oral vinorelbine

✍ Tubiana-Mathieu, N; Bougnoux, P; Becquart, D; Chan, A; Conte, P-F; Majois, F; Es 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB

2130 POSTER Updated analysis of an inter

✍ N. Tubiana-Mathieu; P. Bougnoux; D. Becquart; A. Chan; F. Majois; M. Espie; O. P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

First-line trastuzumab (H), oral vinorel

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; L. Goedhals; M. Gil G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

232 Final Results of a Phase II Study of

✍ L. Petruzelka; V. Ganju; P.F. Conte; N. Tubiana-Mathieu; F. Majois; M. Espie; A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

446 PUBLICATION A phase II trial of tras

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

5081 Triple combination of 3-weekly tras

✍ R. Palumbo; A. Bernardo; M.R. Strada; G. Poggi; C. Teragni; A. Amatu; M. Frascar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB